Institut Régional de Médecine Physique et de Réadaptation
Nancy, 54000, France
Location status: Recruiting
Location contact
Amelie Touillet
PRINCIPAL_INVESTIGATOR
Christelle Requena
CONTACT
Jonathan Pierret, PhD
CONTACT
NCT Number: NCT07191795
Following lower-limb amputation, the loss of somatosensory information from the missing limb renders walking less automatic, more cognitively demanding, and often asymmetric, which can lead to secondary pathologies.
Hypothesis: This study is based on the hypothesis that phantom limb sensations (PLS), when coherent with the prosthetic device's movements and the phases of the gait cycle, can compensate for the loss of somatosensory feedback and thereby improve locomotion for individuals with amputation. It is further hypothesized that it is possible to artificially induce these coherent and useful sensations, notably through "referred sensations" elicited by stimulation of the residual limb (e.g., via the prosthetic socket).
Objectives: The project aims to:
* Determine whether the natural presence of phantom limb sensations during walking impacts gait parameters. * Confirm in a larger patient population that modifications to the prosthetic socket can induce or enhance phantom sensations that are perceived as useful for walking. * Investigate whether these perceptual changes (induced or enhanced) are associated with objective, measurable improvements in gait quality.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Nancy, 54000, France
Location status: Recruiting
Amelie Touillet
PRINCIPAL_INVESTIGATOR
Christelle Requena
CONTACT
Jonathan Pierret, PhD
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants with unilateral amputations and a control group will undergo a comprehensive walking analysis. In a lab setting (on a treadmill or floor), their gait will be recorded using inertial sensors, EMG, force plates, and motion capture, while an EEG cap and a NASA-TLX questionnaire will assess cognitive load. Capable participants will also perform a walking test on a real-world outdoor course with varied terrain. The data will be analyzed to compare walking patterns between groups (amputees vs. controls, and amputees with vs. without phantom limbs). Finally, participants will describe any interactions they perceived between their phantom sensations and walking during the tests.
Participants reporting referred sensations in gait analysis phase will undergo further testing. The study will investigate whether prosthesis pressure or a specific socket interaction causes these sensations. A 3x3 cm grid will be drawn on the residual limb to systematically map referred sensations using various stimuli (brush, pressure tip, electrical stimulation). Participants will rate the intensity and describe the location of any resulting phantom sensations. This mapping will be repeated after 6 months to assess the stability of these sensations over time, with the ultimate goal of potentially using them to provide sensory feedback for prosthesis users. The session will last approximately 2 hours.
Unilateral transfemoral amputees with detailed referred sensation maps will have their brain activity recorded using a 64-electrode EEG cap. Non-invasive stimuli will be applied to four specific sites: an area on the residual limb that elicits a referred sensation, the corresponding location on the intact foot, a neutral area on the residual limb, and its corresponding location on the intact thigh. This process, involving 400 total stimulations, will be repeated after 6 months to track cortical changes. Non-amputee participants will also be tested as a control group to check for symmetry in brain responses to thigh stimulation. Each session lasts about 2 hours.
This phase will evaluate how socket modifications affect phantom sensations and walking in 10 transfemoral amputees. First, the best material to comfortably induce referred sensations will be determined in a small sub-study. Then, each participant will be tested under four conditions: their usual socket and a socket with different rigidity, both with and without a specific local pressure point added inside. The location of this pressure point is based on the user's sensation map. Participants' walking will be analyzed in both lab and real-world environments for each condition, and they will provide feedback on their sensations and which setup they find most helpful. The evaluation involves 4 sessions over 2-3 months
A semi-structured interview will be conducted to ask participants to describe their phantom limb sensations (type, location, intensity) under three conditions: without their prosthesis, while standing with it, and while walking with it. This aims to identify factors influencing these sensations. Additionally, a brief physical examination of the residual limb will be performed to see if touch in specific areas triggers any referred sensations.
Time frame: The first day of the study
A composite assessment of phantom limb sensations will be conducted via a semi-structured interview. Data collected will include:
Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
The participant's average walking speed, measured in meters per second (m/s). The measurement will be collected using inertial measurement units (IMUs) and/or a Vicon motion capture system while the participant walks on hard ground or on a treadmill at their self-selected speed.
Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
Gait symmetry will be calculated based on the stride length of the affected (or corresponding) limb and the healthy limb. The symmetry index is a unitless ratio (or percentage) that quantifies the difference between the two limbs. A value of 1 (or 100%) indicates perfect symmetry. Measured using inertial measurement units or the Vicon system.
Time frame: 2nd or 3rd day of the study depending on whether the participant with an amputation was included in phase 2 or not and during the 6-month follow-up visit.
The total surface area capable of triggering phantom sensations will be measured. For each type of stimulation (brush, pressure, point, electrical), the number of 3x3 cm areas causing a sensation will be counted. The total surface area (in cm²) will be calculated by multiplying this number by 9. A map will be generated for each stimulation modality.
Time frame: 2nd or 3rd day of the study depending on whether the participant with an amputation was included in phase 2 or not and during the 6-month follow-up visit.
When each reactive area is stimulated, the participant will rate the intensity of the phantom sensation perceived on a 6-point Numerical Rating Scale (NRS), ranging from 0 (no sensation) to 5 (maximum intensity imaginable). The average intensity of the reactive areas will be calculated for each type of stimulation.
Time frame: The second day of the study for participants with amputation
The recorded EEG activity will be used to model and locate the source of the maximum cortical response. The primary outcome measure will be the coordinates (e.g., in the MNI or Talairach atlas) of the center of activation in the somatosensory cortex. The objective is to compare the source localization obtained during ecological gait after each demanding walking situation.
Time frame: Day 7 of the study
At the end of the four test sessions, participants will be asked to rank the four conditions (rigidity A/B, with/without focal pressure) from most to least conducive to walking. The primary outcome will be the condition ranked first by the largest number of participants.
Time frame: Days 4 to 7 to the study
Several key walking parameters (speed in m/s, cadence in steps/min, step symmetry index) will be measured using inertial sensors during the outdoor walk. The analysis will compare the average values of these parameters between the four socket conditions.
Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
The number of steps per minute (steps/min) when walking at a comfortable speed. Measured using inertial measurement units or the Vicon system.
Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
The electrical activity of key muscle groups (e.g., quadriceps, hamstrings, glutes, paravertebral muscles) will be recorded using surface electromyography (EMG). The analysis will focus on the timing and amplitude of muscle activation to assess motor coordination.
Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
The maximum force exerted on the ground with each step, measured in Newtons (N) or as a percentage of body weight (%BW). The measurement will be taken using force platforms (AMTI), pressure insoles (Loadsol), or an instrumented mat (Zeno).
Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
The cognitive load perceived by the participant will be assessed using the NASA Task Load Index (NASA-TLX) self-report questionnaire. The total score, ranging from 0 to 100, will be calculated. A higher score indicates a greater perceived cognitive load.
Time frame: The second day of the study for participants with amputation
Electroencephalographic (EEG) activity will be recorded via a headset. Cognitive load will be quantified by analyzing the power ratio in specific frequency bands at the frontal electrodes.
Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
The average walking speed (in m/s) measured using inertial measurement units and pressure soles (Loadsol) during a predefined outdoor route including various difficulties (stairs, slopes, etc.).
Time frame: The second day of the study for participants with amputation
Participants' verbal descriptions of the nature of the interaction (facilitating, hindering, neutral), the evolution and characteristics of phantom sensations during walking will be collected via a structured interview at the end of the session. The data will be analyzed thematically.
Time frame: The first day of the study and during the 6-month follow-up visit.
For the subgroup of participants with an amputation of less than 6 months at inclusion, the intensity of phantom sensations will be re-assessed using the 3-point ordinal scale.
Time frame: Day 3 of the study
For the subgroup of participants reporting interaction between sensations and focal stimulation after various stimulations using a rubber tip (pressure), a brush, and a needle. The change in sensation intensity (rated on a scale of 0 to 5). The result will be categorized as "increase," "decrease," or "no change."
Time frame: Day 4 to 7 of the study
Perceived mental workload will be assessed using the NASA-TLX questionnaire immediately after each walking session. The total score will be compared between the four socket conditions.
Time frame: Day 4 to 7 of the study
The overall comfort perceived for each condition will be assessed at the end of each session using a Numerical Rating Scale (NRS) ranging from 0 (very uncomfortable) to 10 (very comfortable). The average score will be compared between the four conditions.
Time frame: Day 4 to 7 of the study
For each condition, a structured description of the sensations reported (type, location, intensity, perceived usefulness for walking) will be collected through an interview. The data will be analyzed thematically to compare the sensory experience.
Contact information is provided by the study sponsor or research team.
Christelle C Requena
CONTACT
Jonathan J Pierret, PhD
CONTACT
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
Other
Acronym: PhantomWalk
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07706452
Amputation, Traumatic, Balance Impairment
Gaza, Gaza Strip, Palestinian Territories
View Trial DetailsNCT05830630
Lower Limb Amputation, Methylene Blue
Tanta, Gharbia Governorate, Egypt
View Trial DetailsNCT06415955
Lower Limb Amputation
Nîmes, Gard, France
View Trial DetailsNCT04030650
Lower Limb Amputation
Dijon, France
View Trial Details